113 related articles for article (PubMed ID: 12227974)
1. Social network, social support and the rate of decline of CD4 lymphocytes in asymptomatic HIV-positive homosexual men.
Persson L; Ostergren PO; Hanson BS; Lindgren A; Naucler A
Scand J Public Health; 2002; 30(3):184-90. PubMed ID: 12227974
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
Margolick JB; Muñoz A; Vlahov D; Astemborski J; Solomon L; He XY; Nelson KE; Saah AJ
Arch Intern Med; 1994 Apr; 154(8):869-75. PubMed ID: 7908795
[TBL] [Abstract][Full Text] [Related]
3. The role of family and friend social support in reducing risk behaviors among HIV-positive Gay men.
Kimberly JA; Serovich JM
AIDS Educ Prev; 1999 Dec; 11(6):465-75. PubMed ID: 10693644
[TBL] [Abstract][Full Text] [Related]
4. HIV infection: social network, social support, and CD4 lymphocyte values in infected homosexual men in Malmö, Sweden.
Persson L; Gullberg B; Hanson BS; Moestrup T; Ostergren PO
J Epidemiol Community Health; 1994 Dec; 48(6):580-5. PubMed ID: 7830013
[TBL] [Abstract][Full Text] [Related]
5. The sociodemographic profile, risk categories and prevalence of HIV infection among people attending a London same-day testing clinic, 2000-2001.
Sinclair M; Bor R; Evans A; Glass D; Levitt D; Johnson MA
Int J STD AIDS; 2004 Jan; 15(1):33-7. PubMed ID: 14769169
[TBL] [Abstract][Full Text] [Related]
6. Prostate carcinoma among men with human immunodeficiency virus infection.
Crum NF; Spencer CR; Amling CL
Cancer; 2004 Jul; 101(2):294-9. PubMed ID: 15241826
[TBL] [Abstract][Full Text] [Related]
7. [Perceived emotional support of HIV-positive men in relation to the stage of the disease].
Wöller W; Arendt G; Kruse J; Boström J
Psychother Psychosom Med Psychol; 1995 Jun; 45(6):208-14. PubMed ID: 7624472
[TBL] [Abstract][Full Text] [Related]
8. Low CD4 T cell counts before HIV-1 seroconversion do not affect disease progression in Ethiopian factory workers.
Mekonnen Y; Geskus RB; Hendriks JC; Messele T; Borghans J; Miedema F; Wolday D; Coutinho RA; Dukers NH
J Infect Dis; 2005 Sep; 192(5):739-48. PubMed ID: 16088823
[TBL] [Abstract][Full Text] [Related]
9. Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study.
Olley BO; Seedat S; Stein DJ
J Psychosom Res; 2006 Oct; 61(4):479-84. PubMed ID: 17011355
[TBL] [Abstract][Full Text] [Related]
10. Association of asymptomatic oral candidal carriage, oral candidiasis and CD4 lymphocyte count in HIV-positive patients in China.
Liu X; Liu H; Guo Z; Luan W
Oral Dis; 2006 Jan; 12(1):41-4. PubMed ID: 16390467
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with sexual problems in HIV-positive gay men.
Cove J; Petrak J
Int J STD AIDS; 2004 Nov; 15(11):732-6. PubMed ID: 15537458
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
[TBL] [Abstract][Full Text] [Related]
13. Psychological distress, life stressors, and social support in new immigrants with HIV.
Cohen M; Arad S; Lorber M; Pollack S
Behav Med; 2007; 33(2):45-54. PubMed ID: 17711806
[TBL] [Abstract][Full Text] [Related]
14. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
15. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
Hurwitz BE; Klaus JR; Llabre MM; Gonzalez A; Lawrence PJ; Maher KJ; Greeson JM; Baum MK; Shor-Posner G; Skyler JS; Schneiderman N
Arch Intern Med; 2007 Jan; 167(2):148-54. PubMed ID: 17242315
[TBL] [Abstract][Full Text] [Related]
16. Presentation and reasons for HIV-1 testing in Saudi Arabia.
Alrajhi AA; Halim MA; Al-Abdely HM
Int J STD AIDS; 2006 Dec; 17(12):806-9. PubMed ID: 17212855
[TBL] [Abstract][Full Text] [Related]
17. Over fifty and living with HIV in London.
Elford J; Ibrahim F; Bukutu C; Anderson J
Sex Transm Infect; 2008 Nov; 84(6):468-72. PubMed ID: 19028949
[TBL] [Abstract][Full Text] [Related]
18. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
[TBL] [Abstract][Full Text] [Related]
19. Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002.
Dorrucci M; Phillips AN; Longo B; Rezza G;
AIDS; 2005 Feb; 19(3):331-5. PubMed ID: 15718844
[TBL] [Abstract][Full Text] [Related]
20. Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals.
Sterling TR; Pisell-Noland T; Perez JL; Astemborski J; McGriff JR; Nutting L; Hoover DR; Vlahov D; Bollinger RC
J Infect Dis; 2005 Mar; 191(6):881-5. PubMed ID: 15717262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
